Medical Insights with Dr. Thomas Blom

In this episode of Medical Insights, Dr. Thomas Blom sits down with Dr. Josh Pepek , a leading radiation oncologist in Central New Jersey with Aster Care. Together, they break down the complex decision-making process for men diagnosed with early-stage prostate cancer. From understanding the Gleason score and risk stratification to the nuances of active surveillance, this deep dive explores how modern medicine is moving toward highly individualized care. Whether you are a patient, a family member, or a medical professional, this episode provides a clear map of the current landscape of prostate cancer treatment.Key Topics Covered:* Risk Stratification: Understanding Low, Intermediate, and High-risk categories using NCCN guidelines.* Active Surveillance: Who can safely watch and wait to avoid treatment side effects?* Radiation vs. Surgery: A candid look at how comorbidities, age, and urinary symptoms influence the choice between a prostatectomy and radiation.* Side Effect Management: How new technologies like perirectal spacers (Hydrogel) are significantly reducing rectal toxicity.* Treatment Modalities: A breakdown of IMRT (Intensity Modulated Radiation Therapy), Brachytherapy (seeds), and the role of Hormone Therapy (ADT).About the Guest:Dr. Joseph Pepek is a radiation oncologist based in Central New Jersey. He specializes in utilizing advanced radiation techniques to treat localized cancers while prioritizing the patient’s quality of life and long-term outcomes.About the Podcast:Medical Insights with Dr. Thomas Blom provides in-depth conversations with specialists to bridge the gap between complex medical data and patient-centered care. #ProstateCancer #RadiationOncology #MensHealth

In this episode of Medical Insights, Dr. Thomas Blom sits down with Dr. Sheetal Shrimanker, a hematologist-oncologist at Penn Medicine, to demystify the complex world of plasma cell disorders. Receiving a lab result showing an "abnormal protein" can be a frightening experience. Dr. Shrimanker explains exactly what a monoclonal protein is, how physicians risk-stratify patients, and the crucial differences between a benign condition like MGUS and active Multiple Myeloma.In This Episode:* The First Red Flag: What is a monoclonal protein and why is it often found by accident?* MGUS vs. Smoldering Myeloma: Understanding the 1% annual risk of progression and when a bone marrow biopsy is necessary.* The CRAB Criteria: How specialists look for end-organ damage (Calcium, Renal, Anemia, Bone).* Modern Staging: Why traditional cancer stages don't apply to blood cancers and how cytogenetics (DNA testing) dictates the plan.* Treatment Pathways: A look at induction therapy, stem cell transplants, and the role of medications like Daratumumab.* The Future of Care: An introduction to Bi-specific Antibodies and CAR T-cell therapy.About Our Guest:Dr. Sheetal Shrimanker is a board-certified hematologist-oncologist practicing with Penn Medicine in Princeton, New Jersey. She specializes in treating blood-based malignancies and guiding patients through complex immunotherapy and transplant journeys.0:00 Introduction to Monoclonal Proteins2:24 Workup for Monoclonal Proteins (MGUS)4:43 Criteria for Bone Marrow Biopsy & Imaging6:23 Causes of MGUS (Viruses & Autoimmune)7:42 Prognosis and Risk Counseling9:39 Distinguishing MGUS, Smoldering Myeloma, and Multiple Myeloma11:42 Staging and Cytogenetics14:48 Treatment Pathways & Induction Therapy18:34 Stem Cell Transplants19:56 Managing Risks (Infection, Blood Clots)22:36 Future Care: CAR T-Cell Therapy24:28 Bi-specific Antibodies26:53 Treating Smoldering Myeloma 28:34 Genetic Predisposition 29:52 Monoclonal Gammopathy of Renal/Neurological Significance 31:52 Related Disorders (Waldenström’s & Amyloidosis) 34:19 Long-term Management, Maintenance, and IVIG#cancerresearch

Join host Dr. Thomas Blom and guest Dr. Rohit Bhalla as they provide a comprehensive overview of infection risks for chemotherapy patients and practical strategies to prevent them, including vaccination, masking, and lifestyle modifications. Dr. Rohit Bhalla, an infectious disease specialist, shares expert insights on immune system management, travel precautions, and specific risks for patients with conditions like asplenia and undergoing bone marrow transplants.This episode equips patients and clinicians with actionable insights to minimize infection risks during chemotherapy and beyond, emphasizing proactive vaccination, hygiene, and environmental precautions.Main Topics:How chemotherapy impacts immune function and infection risk timelineEssential vaccinations before and during chemotherapyBest practices for infection prevention: masking, hygiene, and pet careRisks associated with neutropenic periods and dietary precautionsProphylactic medications and growth factor support to reduce infection riskSpecial considerations for patients with spleen removal or bone marrow transplantsEmerging infectious threats like Babesia and their geographic patterns

In this episode of Medical Insights with Dr. Thomas Blom, host Dr. Blom welcomes Dr. Joseph Ho, a Hematologist-Oncologist from the Princeton Medical Group. Together, they demystify Chronic Lymphocytic Leukemia (CLL), a diagnosis that often sounds urgent and frightening but frequently follows a very different path than other cancers.From the initial shock of the word "leukemia" to modern, chemotherapy-free treatment options, this conversation provides a comprehensive overview for patients and families navigating a CLL diagnosis.Key Topics Covered:•Leukemia vs. Lymphoma: Understanding why CLL is considered a chronic, low-grade, and often non-aggressive disease rather than an immediate medical emergency.•The "Watch and Wait" Paradigm: Why two-thirds to three-fourths of patients start with surveillance rather than active treatment. Dr. Ho explains why "stirring the pot" too early isn't always best for the patient.•Triggers for Treatment: What doctors look for—such as drenching night sweats, fatigue, rapid white blood cell doubling time, or specific genetic markers like the p53 mutation—before starting therapy.•Modern Treatment Options: How the field has moved away from traditional chemotherapy toward targeted oral therapies like Acalabrutinib and Venetoclax•Living with CLL: Practical advice on vaccinations (including the importance of the Shingrix vaccine), infection risks, and maintaining a normal lifestyle without "living in a bubble".•Long-term Risks & Family Planning: Discussing the slightly increased risk for skin cancers and the familial (but not directly inherited) nature of the disease.About the Guest:Dr. Joseph Ho is a Hematologist-Oncologist at the Princeton Medical Group in Princeton, New Jersey. He specializes in the treatment of blood cancers and provides expert insights into the evolving landscape of CLL management.

Navigating end-of-life care decisions is one of the most emotionally complex challenges patients and their families face during a cancer journey. Dr. Michael Levitt, a medical oncologist with Hackensack Meridian Health and director of hospice services for Swan Hospice in New Jersey, clarifies the often-misunderstood realities of palliative and hospice care to help families make informed, compassionate choices.Key TakeawaysUnderstand the critical distinction between palliative care, which can be utilized alongside active cancer treatments, and hospice care, which focuses entirely on comfort and symptom management.Discover the comprehensive, team-based benefits of hospice, which include covered medical equipment, social workers, clergy, and home health aides to support both the patient and the family.Learn the importance of establishing a POLST (Practitioner Orders for Life-Sustaining Treatment) form to clearly define advanced directives regarding life support and artificial feeding.Master the realities of the New Jersey Medical Marijuana Program as a legal, effective adjunct for managing chronic pain, nausea, and treatment toxicities when traditional prescriptions fall short.

In this episode Dr. Blom is joined by Dr. Amit Mehta, a practicing oncologist from North Carolina with extensive expertise in prostate cancer. Together, they demystify metastatic prostate cancer from the patient's perspective, answering the most pressing questions about diagnosis, advanced treatment options, and navigating daily lifestyle changes.Key TakeawaysDiscover the fundamental differences between imaging modalities, including CT scans, bone scans, and PSMA PET scans, to accurately stage the disease.Learn how genetic testing, particularly for the BRCA2 gene, not only assesses hereditary risk for family members but also opens doors to targeted combination therapies that significantly extend treatment efficacy.Understand the critical importance of continuous androgen deprivation therapy and why maintaining suppressed testosterone levels maximizes long-term survival odds.Master actionable nutritional strategies supported by medical data, such as incorporating green tea and vitamin D while avoiding whole milk, to complement your prescribed medical treatments.

Get to know Dr. Thomas Blom, a board-certified oncologist and hematologist serving the greater Princeton New Jersey region, as he launches a new podcast to demystify complex cancer care. In this premier episode, podcast producer Kenneth Greenberg introduces Dr. Blom who discusses the doctor-patient relationship, offering a rare, behind-the-scenes look at how physicians approach life-altering diagnoses and formulate actionable treatment plans.Key TakeawaysDiscover what drives a physician's passion for hematology and oncology through decades of rapid medical advancements.Learn effective strategies for digesting complex medical information, including why receiving difficult news over the phone at home can give patients the necessary space to process.Master the expectations of patient care by understanding how specialized oncologists prioritize straightforward communication and immediate treatment options.Explore the crucial upcoming discussions planned for patients and families, ranging from managing complications like "chemo brain" and neuropathy, to navigating chronic lymphocytic leukemia and end-of-life care.